These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15154001)

  • 21. [Anxiolytic action of sodium valproate (possible role of gamma-aminobutyric acid in affective disorders)].
    Raevskiĭ KS; Aleksandrovskiĭ IuA; Poiurovskiĭ MV; Kharlamov AN; Neznamov GG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):574-9. PubMed ID: 2860764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gabergic compounds and schizophrenia.
    van den Berg CJ
    Lancet; 1976 Dec; 2(7998):1301-2. PubMed ID: 63774
    [No Abstract]   [Full Text] [Related]  

  • 23. Valproate for management of idiopathic olfactory hallucinosis.
    Chauhan S; Tripathi P; Khanna A; Goyal P
    Aust N Z J Psychiatry; 2014 Dec; 48(12):1172-3. PubMed ID: 25228661
    [No Abstract]   [Full Text] [Related]  

  • 24. GABA and schizophrenia: a review of basic science and clinical studies.
    Wassef A; Baker J; Kochan LD
    J Clin Psychopharmacol; 2003 Dec; 23(6):601-40. PubMed ID: 14624191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stiff-person syndrome].
    Sakai K
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():838-41. PubMed ID: 12387093
    [No Abstract]   [Full Text] [Related]  

  • 26. Difficulties in the medical treatment of prolactinoma in a patient with schizophrenia--a case report with a review of the literature.
    Konopelska S; Quinkler M; Strasburger CJ; Ventz M
    J Clin Psychopharmacol; 2008 Feb; 28(1):120-2. PubMed ID: 18204364
    [No Abstract]   [Full Text] [Related]  

  • 27. gamma-Aminobutyric-acid deficiency in schizophrenia.
    Koran LM
    Lancet; 1976 Nov; 2(7993):1025. PubMed ID: 62243
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
    Ishizaki T; Chiba K; Saito M; Kobayashi K; Iizuka R
    J Clin Psychopharmacol; 1984 Oct; 4(5):254-61. PubMed ID: 6149238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic downregulation of GABAergic function in schizophrenia: potential for pharmacological intervention?
    Costa E; Grayson DR; Guidotti A
    Mol Interv; 2003 Jun; 3(4):220-9. PubMed ID: 14993449
    [No Abstract]   [Full Text] [Related]  

  • 30. Migraine relief.
    Zurlinden J
    Nurs Spectr (Wash D C); 1997 Sep; 7(18):10. PubMed ID: 9439315
    [No Abstract]   [Full Text] [Related]  

  • 31. Relief for migraine sufferers.
    Zurlinden J
    Nurs Spectr (Gt Phila Tri State Ed); 1998 Jan; 7(1):23. PubMed ID: 9546885
    [No Abstract]   [Full Text] [Related]  

  • 32. A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache.
    Bakhshayesh B; Seyed Saadat SM; Rezania K; Hatamian H; Hossieninezhad M
    Am J Emerg Med; 2013 Mar; 31(3):540-4. PubMed ID: 23380105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
    Nair NP; Lal S; Schwartz G; Thavundayil JX
    Adv Biochem Psychopharmacol; 1980; 24():437-41. PubMed ID: 6773303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sodium valproate--current status of pharmacological research].
    Chapman AG
    Praxis (Bern 1994); 1994 Oct; 83(40):1106-10. PubMed ID: 7524125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hyponatremia in a chronic schizophrenic patient.
    Ahlawat SK
    J Assoc Physicians India; 1999 Jul; 47(7):724-6. PubMed ID: 10778596
    [No Abstract]   [Full Text] [Related]  

  • 38. Valproate prescribing trends for non-epilepsy indications in women of reproductive age warrants effective measures and increased surveillance.
    Kaplan YC; Abdelkader N
    Seizure; 2016 Aug; 40():13-4. PubMed ID: 27289305
    [No Abstract]   [Full Text] [Related]  

  • 39. Stupor and fast activity on electroencephalography in a child treated with valproate.
    Mastrangelo M; Mariani R; Spalice A; Rocchi V; Iannetti P
    Pediatr Neurol; 2009 Jul; 41(1):53-6. PubMed ID: 19520277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium valproate for tinnitus.
    Menkes DB; Larson PM
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):803. PubMed ID: 9810969
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.